Filing Details

Accession Number:
0000874015-10-000030
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-29 20:09:35
Reporting Period:
2010-12-27
Filing Date:
2010-12-29
Accepted Time:
2010-12-29 20:09:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874015 Isis Pharmaceuticals Inc ISIS Pharmaceutical Preparations (2834) 330336973
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1073387 Frank C Bennett C/O Isis Pharmaceuticals, Inc.
1896 Rutherford Road
Carlsbad CA 92008
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-12-27 7,700 $9.63 8,261 No 4 M Direct
Common Stock Disposition 2010-12-27 7,700 $10.42 561 No 4 S Direct
Common Stock Acquisiton 2010-12-29 4,600 $9.63 5,161 No 4 M Direct
Common Stock Disposition 2010-12-29 4,600 $10.32 561 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2010-12-27 7,700 $0.00 7,700 $9.63
Common Stock Employee Stock Option (right to buy) Disposition 2010-12-29 4,600 $0.00 4,600 $9.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,600 2005-01-02 2011-01-01 No 4 M Direct
0 2005-01-02 2011-01-01 No 4 M Direct
Footnotes
  1. Acquired as a result of exercising a stock option that was scheduled to expire on 1/1/11. The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/2/10.
  2. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/2/10.